Stuttgart, Germany – 31st of August 2015 – Impulse Dynamics informed today that the registration of the Optimizer IVs device was approved in Brazil. Impulse Dynamics is showing global growth of its innovative technology. The Optimizer IVs is a minimally invasive implantable device designed to treat Chronic Heart Failure (CHF). It has already been successfully launched in Europe and is available in cardiology centers in various countries. The CCM therapy has been implanted in over 2500 patients to date and is the only device therapy available for patients with narrow QRS complex. Impulse Dynamics “We are very pleased to provide the CCM therapy, delivered by the Optimizer IVs device to patients in Brazil”
Impulse Dynamics N.V. is focused on the development of electrical therapies for the treatment of chronic heart failure. As a global leader in cardiac medical innovation, Impulse Dynamics has operations in the US, Europe, Asia and Australia. For more information please visit www.impulse-dynamics.com.
Impulse Dynamics is a member of the Hobart Group, an international portfolio of medical device companies that includes over 100 scientists, engineers, regulatory and business experts. The group, founded by Professor Shlomo Ben-Haim, accelerates ideas, develops and commercializes technologies targeting top medical markets with significant unmet needs and large exit potentials including cardiology, diabetes, oncology, neurology, and rehabilitation. Additional information can be found at www.hobart-group.com.